A new study finds diet quality and waist-to-hip ratio strongly impact brain function as you age.
An international group of medical experts says body mass index is not a reliable way to diagnose obesity. Members of the Commission on Clinical Obesity are recommending new methods that also consider location of excess body fat and objective symptoms of disease.
A new study finds using GLP-1 receptor agonists to treat obesity in otherwise healthy adults is safe and very effective.
New study examines U.S. trends in body mass index and obesity and finds improving numbers, driven in part by GLP-1 weight-loss drugs.
Researchers are now testing a new semaglutide delivery platform that combines the medication with a special hydrogel to achieve sustained release over one month or longer.
A new study finds overweight people who stay awake too late face higher odds of metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke and diabetes.
Splenda doesn’t directly add calories to your diet, but the sweetener still might lead people to pack on pounds, a new study says.
The sugar substitute might spur on a person’s appetite and feelings of hunger, potentially leading them to overeat, according to...
Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24.
The drug, cal...
Purposeful splishing and splashing can help you trim your waist size and drop excess pounds, a new evidence review has concluded.
Water aerobics led to about 6 pounds of weight loss and more than an inch off the waists of overweight and obese people, researchers reported...
Despite recent concerns that taking Ozempic, Wegovy or other GLP-1 medications might be unsafe before a surgery, a new review has uncovered no such danger.
The issue arose because weight-loss drugs slow gastric emptying. The thought was that food might linger in the stom...